Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2423
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorGORDON, Pedro Caldana-
dc.contributor.authorXAVIER, Josefa Cynara-
dc.contributor.authorLOUZA, Mario Rodrigues-
dc.date.accessioned2013-09-23T16:55:12Z-
dc.date.available2013-09-23T16:55:12Z-
dc.date.issued2013-
dc.identifier.citationNEUROPSYCHIATRIC DISEASE AND TREATMENT, v.9, p.133-138, 2013-
dc.identifier.issn1176-6328-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2423-
dc.description.abstractBackground: In the last few decades, a large number of studies have produced compelling evidence that patients with schizophrenia are at increased risk for developing several medical conditions and diseases, including obesity, metabolic disturbances, and cardiovascular diseases. Several protocols have been designed with the aim of reducing such risk. Objective: To investigate current physical health status in a population of outpatients with schizophrenia. Methods: A cross-sectional study was conducted in our outpatient clinic, selecting subjects who met DSM-IV diagnosis criteria for schizophrenia. Data were collected regarding clinical characteristics, lifestyle, medication in use, and biometric and laboratory parameters. Results: A total of 261 patients were included. We found a high prevalence of elevated body mass index (BMI > 25) (70%), dyslipidemia (73.2%), and metabolic syndrome (28.7%). Patients' ages were associated with worsened lipid profiles, but other variables, such as disorder duration or type of antipsychotic in use, were not associated with any metabolic disturbance. Despite the increased prevalence of these conditions, only a small portion of the sample was under regular medical treatment. Conclusion: Outpatients with schizophrenia show signs of poor physical health conditions. These findings reinforce the need for an intensive and appropriate approach to assure that these patients receive adequate clinical referral and treatment.-
dc.language.isoeng-
dc.publisherDOVE MEDICAL PRESS LTD-
dc.relation.ispartofNeuropsychiatric Disease and Treatment-
dc.rightsopenAccess-
dc.subjectpsychosis-
dc.subjectpublic health-
dc.subjectantipsychotic drugs-
dc.subjectcardiovascular disorders-
dc.subject.otheratypical antipsychotics-
dc.subject.othercatie schizophrenia-
dc.subject.otherprevalence-
dc.subject.othermortality-
dc.subject.otherillness-
dc.subject.otherobesity-
dc.subject.otherrisk-
dc.subject.otherdyslipidemia-
dc.subject.othermetaanalysis-
dc.subject.othercholesterol-
dc.titleWeight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia-
dc.typearticle-
dc.rights.holderCopyright DOVE MEDICAL PRESS LTD-
dc.identifier.doi10.2147/NDT.S37019-
dc.identifier.pmid23355783-
dc.subject.wosClinical Neurology-
dc.subject.wosPsychiatry-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage133-
hcfmusp.description.endpage138-
hcfmusp.description.volume9-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84872859043-
hcfmusp.origem.idWOS:000313578800001-
hcfmusp.publisher.cityALBANY-
hcfmusp.publisher.countryNEW ZEALAND-
hcfmusp.relation.referenceAllison DB, 1999, AM J PSYCHIAT, V156, P1686-
hcfmusp.relation.referenceBakx JC, 2000, PREV MED, V30, P138, DOI 10.1006/pmed.1999.0608-
hcfmusp.relation.referenceBarnett AH, 2007, J PSYCHOPHARMACOL, V21, P357, DOI 10.1177/0269881107075509-
hcfmusp.relation.referenceBrown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502-
hcfmusp.relation.referenceDaumit GL, 2008, SCHIZOPHR RES, V105, P175, DOI 10.1016/j.schres.2008.07.006-
hcfmusp.relation.referenceDe Hert M, 2011, WORLD PSYCHIATRY, V10, P52-
hcfmusp.relation.referenceDe Hert M, 2008, SCHIZOPHR RES, V101, P295, DOI 10.1016/j.schres.2008.01.028-
hcfmusp.relation.referenceDe Hert M, 2011, WORLD PSYCHIATRY, V10, P138-
hcfmusp.relation.referenceCleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486-
hcfmusp.relation.referenceGigante DP, 2009, REV SAUDE PUBL, V43, P83, DOI 10.1590/S0034-89102009000900011-
hcfmusp.relation.referenceGrundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404-
hcfmusp.relation.referenceHennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007-
hcfmusp.relation.referenceLeitao-Azevedo CL, 2006, REV BRAS PSIQUIATR, V28, P301, DOI 10.1590/S1516-44462006005000016-
hcfmusp.relation.referenceLeucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x-
hcfmusp.relation.referenceLeucht S, 2009, LANCET, V373, P31, DOI [10.1016/S0140-6736(08)61764-X, 10.1016/S01406736(08)61764-X]-
hcfmusp.relation.referenceLieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688-
hcfmusp.relation.referenceMajadas S, 2012, COMPR PSYCHIAT, V53, P145, DOI 10.1016/j.comppsych.2011.03.009-
hcfmusp.relation.referenceMeyer JM, 2008, SCHIZOPHR RES, V101, P273, DOI 10.1016/j.schres.2007.12.487-
hcfmusp.relation.referenceMillen BA, 2011, J PSYCHOPHARMACOL, V25, P639, DOI 10.1177/0269881110370505-
hcfmusp.relation.referenceMisawa F, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-118-
hcfmusp.relation.referenceMitchell AJ, 2012, PSYCHOL MED, V42, P125, DOI 10.1017/S003329171100105X-
hcfmusp.relation.referenceNewcomer JW, 2005, CNS DRUGS, V19, P1-
hcfmusp.relation.referencePadmavati R, 2010, SCHIZOPHR RES, V121, P199, DOI 10.1016/j.schres.2010.05.010-
hcfmusp.relation.referenceRatliff' JC, 2012, COMPR PSYCHIAT, V53, P1028, DOI 10.1016/j.comppsych.2012.02.003-
hcfmusp.relation.referenceRummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012-
hcfmusp.relation.referenceSaha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123-
hcfmusp.relation.referenceSmith M, 2008, BRIT J PSYCHIAT, V192, P406, DOI 10.1192/bjp.bp.107.037184-
hcfmusp.relation.referenceTeixeira PJR, 2007, REV BRAS PSIQUIATR, V29, P330, DOI 10.1590/S1516-44462007000400007-
hcfmusp.relation.referenceTran E, 2009, CANCER, V115, P3555, DOI 10.1002/cncr.24383-
hcfmusp.relation.referenceVancampfort D, 2012, PSYCHIAT RES-
hcfmusp.relation.referenceAmerican Psychiatric Association, 1994, DIAGN STAT MAN MENT-
dc.description.indexPubMed-
hcfmusp.citation.scopus8-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_GORDON_Weight_gain_metabolic_disturbances_and_physical_health_care_2013.PDFpublishedVersion (English)197.13 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.